Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Acquisition

30 Mar 2012 07:00

Anpario plc ("Anpario", the "Company" or the "Group")

Acquisition of Meriden Animal Health Limited

Highlights

Acquisition of Meriden Animal Health Limited ("Meriden") for up to £4.125 million Meriden's 2011 sales and adjusted profit before interest and tax were £5.35 million and £740,000 respectively Expected to be immediately earnings enhancing Deal increases Anpario's global market share and significantly strengthens its position in China Consideration to be met from the Company's existing cash resources

Anpario plc, one of the leading suppliers of natural high performance feed additives to enhance health, growth and sustainability in global agriculture and aquaculture markets, is pleased to announce the acquisition of Meriden Animal Health Limited for a total consideration of up to £4.125 million.

The acquisition of Meriden brings another strong trading brand to the Anpario Group, broadening its product technology and increasing Anpario's global market share in the feed additive sector.

Meriden based in Bedfordshire in the United Kingdom, supplies the global agriculture and aquaculture markets with natural animal feed additive products. Meriden's Orego-Stim range of products, using essential oils, is the leading brand in its field and is marketed across 60 countries worldwide, with the majority of sales being outside the United Kingdom

Meriden's sales for the 12 months to December 2011 were £5.35 million and adjusted profit before interest and tax was £740,000. Net assets acquired will be at least £1.644 million, the majority being working capital, including cash in excess of £400,000. The acquisition is expected to be immediately earnings enhancing to the Group as a whole.

Meriden has ten full time staff including a technical support team based in a representative office in Malaysia. The majority of production is outsourced to a third party manufacturer based in the United Kingdom. Meriden typically supplies through distributors in the local territories except Australia where the company has a joint venture company.

Meriden has a close and important partnership with its China operation with sales accounting for 26% of Meriden's total sales during 2011. The China business has been growing well and Anpario intends to give further support to this relationship to capitalise on the vast potential of China's agriculture market.

In line with Anpario's strategy, Meriden will be run as a separate business enabling the team to focus on selling and marketing high quality feed additive products around the world. Joining Anpario means Meriden's management team will gain additional support and can benefit from working together with Anpario's research and development resource to develop new and innovative products for sale under the Meriden brand.

The two shareholders and founders, namely, Stephen Harris, Managing Director, and Pamela McLaren, Company Secretary, are to remain with the business in their existing roles and will continue to develop the Meriden business further.

The price payable for Meriden is on a debt free basis but will include estimated excess cash of £400,000. An initial payment of £3.0 million in cash on completion has been made from existing cash resources. The remaining £1.125 million is payable over the next two years, dependent on Meriden achieving certain performance criteria, and of this, £125,000 is to be satisfied by the issue of ordinary shares of Anpario to Meriden's shareholders. Subsequent to the completion of this acquisition, Anpario's cash balances will be in excess of £2.5 million.

The Company expects to announce its results for the year ended 31 December 2011 on 26 April 2012.

Richard Edwards, Executive Vice Chairman of Anpario, commented:

"Meriden Animal Health is a quality business with strong brand recognition for developing 100% natural feed additives. This acquisition increases our global market share in animal feed additives which is benefiting as the agriculture industry looks to use natural based solutions to promote the health and growth of animals for meat consumption.

Meriden's significant presence in China increases our involvement in the world's biggest producer of poultry and pig meat and reinforces our strategy to build more significant positions in emerging agriculture and aquaculture markets. We are delighted to welcome the Meriden team and very much look forward to working with them in achieving continued success with the business."

Enquiries:

Anpario plcRichard Edwards, Executive Vice Chairman +44 (0)7776 417129Karen Prior, Group Finance Director +44 (0)1909 537380

FinnCap +44 (0)20 7600 1658Matthew Robinson / Henrik Persson - Corporate FinanceStephen Norcross - Corporate Broking

Copyright Business Wire 2012

Date   Source Headline
13th Oct 200611:30 amRNSStatement re. Disposal
13th Oct 200611:30 amRNSPossible Acquisition
13th Oct 200611:30 amRNSSuspension - Kiotech Int
29th Sep 20064:56 pmRNSInterim Results - Correction
27th Sep 20067:00 amRNSInterim Results
5th Sep 20062:46 pmRNSDirectorate Change
23rd Aug 20069:10 amRNSDiv currency conversion rate
22nd Aug 200610:28 amRNSDoc re. Interim Report
21st Aug 20069:11 amRNSDirector/PDMR Shareholding
18th Aug 20061:57 pmRNSDirector/PDMR Shareholding
10th Aug 200611:27 amRNSDirector/PDMR Shareholding
7th Aug 200610:20 amRNSDirector/PDMR Shareholding
31st Jul 20068:00 amRNSInterim Results
28th Jul 200611:00 amRNSDirectorate Change
12th Jul 200611:00 amRNSTrading Statement
3rd Jul 20067:00 amRNSChange of Adviser
19th Jun 20064:57 pmRNSNotice of AGM
7th Jun 20063:05 pmRNSDirector/PDMR Shareholding
6th Jun 20067:01 amRNSFinal Results
5th Jun 20064:23 pmRNSChange in registered office
16th May 20063:48 pmRNSDirectorate Change
16th May 20063:44 pmRNSDirectorate Change
10th May 20063:02 pmRNSDirector/PDMR Shareholding
10th May 20062:52 pmRNSChanges to Board
9th May 20061:11 pmRNSDirector/PDMR Shareholding
8th May 20062:55 pmRNSDividend Declaration
8th May 20062:50 pmRNSDirector/PDMR Shareholding
5th May 20064:09 pmRNSDirector/PDMR Shareholding
28th Apr 20062:23 pmRNSDirector/PDMR Shareholding
28th Apr 20062:01 pmRNSDirector/PDMR Shareholding
26th Apr 20064:00 pmRNSAnooraq-Anglo Plats Project
19th Apr 20062:00 pmRNSDirector/PDMR Shareholding
12th Apr 20063:09 pmRNSRhodium Contract Sales
12th Apr 20062:00 pmRNSStatement re. Anglo Platinum
29th Mar 200612:04 pmRNSResults of AGM
20th Mar 20062:00 pmRNSDirector/PDMR Shareholding
15th Mar 200610:00 amRNSCurrency conversion rate
23rd Feb 20069:00 amRNSDirectorate Change
13th Feb 20067:15 amRNSResults of Subsidiary
13th Feb 20067:01 amRNSKola licences agreed
13th Feb 20067:00 amRNSFinal Results
19th Jan 200612:04 pmRNSTrading Statement
10th Jan 200612:21 pmRNSBlocklisting Interim Review
10th Jan 200612:11 pmRNSBlocklisting Interim Review
6th Jan 200612:01 pmRNSAdditional Listing
20th Dec 20059:26 amRNSDirector/PDMR Shareholding
15th Dec 200510:00 amRNSPool agreement at Marikana
30th Nov 20054:30 pmRNSIssue of Options
24th Oct 20054:25 pmRNSDirector/PDMR Shareholding
30th Sep 20057:03 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.